Image-guided radiation therapy for localized prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a precise radiation technique that adapts to your body's daily changes. It may offer better outcomes for men with prostate cancer that hasn't spread outside the pelvic area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have prostate cancer that hasn't spread beyond the pelvic lymph nodes.
- You need to be well enough for daily activities (ECOG score 0-2).
- You haven't had prior radiation to the pelvis or certain prostate treatments like cryosurgery or HIFU.
- You don't have active Crohn's disease, ulcerative colitis, or a rare condition called ataxia telangiectasia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to give high-dose radiation to prostate cancer while using an MRI to precisely target the tumor. It is for early-stage prostate cancer, and aims to reduce side effects by treating only the cancer, not the whole prostate.
This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.
This trial tests a type of radiation that adapts to your body's changes during treatment. It is for men with low- to intermediate-risk prostate cancer that hasn't spread.
This trial tests whether a shorter course of radiation works as well as the usual longer course for people with high-risk prostate cancer. The goal is to keep cancer control while possibly reducing treatment time and inconvenience.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial tests a more precise radiation therapy that targets tumors seen on MRI or special scans, aiming to treat prostate cancer while reducing side effects. It is for men who have not had prostate surgery or previous radiation to the area.
Hear when a new Localized Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.